Literature DB >> 7047756

Immunoselection of oligodendrocytes by magnetic beads. I. Determination of antibody coupling parameters and cell binding conditions.

D H Meier, C Lagenaur, M Schachner.   

Abstract

Oligodendrocytes from early postnatal mouse cerebellum were isolated using polyacrylamide-coated magnetic beads carrying monoclonal antibody to 04 cell surface antigen. Oligodendrocytes were enriched to a purity of 91 +/- 4% starting from a mixed cell population containing approximately 1.5% antigen-positive oligodendrocytes. Viability of 04 antigen-positive oligodendrocytes was approximately 90% as judged by exclusion of trypan blue. Oligodendrocytes were recovered after detachment from the beads with a yield of 19 +/- 6% and after collection by centrifugation onto glass coverslips with yields of approximately 6% of all 04 antigen-positive cells. The final cell yield of oligodendrocytes is approximately 8 x 10(5) cells/gram fresh cerebellar tissue.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7047756     DOI: 10.1002/jnr.490070204

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  4 in total

1.  Isolation and cultivation of mature oligodendroglial cells.

Authors:  H H Althaus; H Montz; V Neuhoff; P Schwartz
Journal:  Naturwissenschaften       Date:  1984-06

2.  Identification and characterization of early glial progenitors using a transgenic selection strategy.

Authors:  K J Chandross; R I Cohen; P Paras; M Gravel; P E Braun; L D Hudson
Journal:  J Neurosci       Date:  1999-01-15       Impact factor: 6.167

3.  Cellular distribution of 04 antigen and galactocerebroside in primary cultures of human foetal spinal cord.

Authors:  J G Dickson; J Kesselring; F S Walsh; A N Davison
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

4.  Cell type-specific binding of Ricinus lectin to murine cerebellar cell surfaces in vitro.

Authors:  H J Sack; M Stöhr; M Schachner
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.